Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Ana Gleisner

Concepts (345)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
60
2026
256
8.700
Why?
Liver Neoplasms
54
2026
776
6.900
Why?
Carcinoma, Hepatocellular
38
2026
370
6.270
Why?
Cholangiocarcinoma
20
2026
110
3.830
Why?
Pancreatic Neoplasms
25
2025
944
3.790
Why?
Bile Duct Neoplasms
19
2026
132
3.520
Why?
Adenocarcinoma
25
2024
927
3.280
Why?
Laparoscopy
10
2026
487
2.980
Why?
Neoplasm Recurrence, Local
26
2026
1160
2.720
Why?
Sentinel Lymph Node
8
2022
49
2.610
Why?
Minimally Invasive Surgical Procedures
8
2026
196
2.390
Why?
Melanoma
12
2022
765
2.350
Why?
Sentinel Lymph Node Biopsy
12
2025
118
2.280
Why?
Skin Neoplasms
12
2022
806
2.270
Why?
Lymph Node Excision
13
2026
174
2.180
Why?
Pancreaticoduodenectomy
11
2024
149
2.100
Why?
Postoperative Complications
27
2026
3034
2.010
Why?
Tumor Burden
18
2026
326
1.910
Why?
Pancreatectomy
8
2025
289
1.710
Why?
Survival Rate
41
2026
2092
1.500
Why?
Robotic Surgical Procedures
4
2026
210
1.470
Why?
Retrospective Studies
98
2026
17438
1.460
Why?
Bilirubin
7
2026
101
1.350
Why?
Prognosis
49
2026
4351
1.330
Why?
Aged
99
2026
26432
1.300
Why?
Lymph Nodes
10
2026
511
1.260
Why?
Colorectal Neoplasms
10
2026
874
1.210
Why?
Middle Aged
107
2026
36619
1.100
Why?
Databases, Factual
20
2025
1493
1.090
Why?
Breast Neoplasms
6
2025
2418
1.080
Why?
Lymphatic Metastasis
17
2026
335
1.030
Why?
Liver Transplantation
12
2025
751
0.970
Why?
Esophageal Neoplasms
8
2025
351
0.920
Why?
Risk Assessment
23
2026
3712
0.870
Why?
Female
119
2026
79499
0.850
Why?
Esophagectomy
4
2021
136
0.850
Why?
Humans
150
2026
146342
0.840
Why?
Male
114
2026
73396
0.810
Why?
Serum Albumin
6
2025
147
0.780
Why?
Conversion to Open Surgery
2
2020
22
0.760
Why?
Thrombelastography
1
2024
182
0.760
Why?
Neoplasm Staging
14
2026
1488
0.750
Why?
alpha-Fetoproteins
5
2025
42
0.750
Why?
Nomograms
2
2022
59
0.740
Why?
Follow-Up Studies
26
2026
5439
0.710
Why?
Carcinoma, Pancreatic Ductal
5
2023
297
0.680
Why?
Rectal Neoplasms
5
2023
160
0.660
Why?
Machine Learning
4
2026
594
0.570
Why?
Colonic Neoplasms
3
2024
259
0.560
Why?
Treatment Outcome
30
2026
11821
0.530
Why?
Head and Neck Neoplasms
6
2019
563
0.500
Why?
Quality of Life
2
2019
3200
0.490
Why?
Metastasectomy
3
2024
19
0.490
Why?
CA-19-9 Antigen
3
2026
36
0.480
Why?
Predictive Value of Tests
10
2026
2113
0.470
Why?
Peritoneal Neoplasms
3
2024
103
0.460
Why?
Neoadjuvant Therapy
11
2023
475
0.450
Why?
Hepatic Artery
2
2026
53
0.450
Why?
Colectomy
3
2013
119
0.450
Why?
Aged, 80 and over
20
2025
8391
0.430
Why?
Liver Failure
3
2009
79
0.420
Why?
Risk Factors
21
2026
10921
0.390
Why?
Disease-Free Survival
11
2025
778
0.390
Why?
Axilla
3
2023
51
0.390
Why?
Length of Stay
8
2026
1358
0.380
Why?
Stomach Neoplasms
2
2024
128
0.370
Why?
Cytoreduction Surgical Procedures
3
2024
69
0.360
Why?
Blood Loss, Surgical
4
2026
117
0.360
Why?
Decision Making
1
2019
993
0.350
Why?
Propensity Score
4
2024
376
0.340
Why?
Ampulla of Vater
2
2024
40
0.330
Why?
Margins of Excision
5
2025
55
0.320
Why?
Decision Support Techniques
2
2025
478
0.310
Why?
ROC Curve
5
2025
617
0.300
Why?
Adult
39
2026
41087
0.300
Why?
United States
19
2025
16136
0.300
Why?
Liver Cirrhosis
5
2025
278
0.290
Why?
Benchmarking
2
2021
193
0.290
Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
15
0.290
Why?
Serum Albumin, Human
2
2025
7
0.290
Why?
Preoperative Care
5
2025
396
0.280
Why?
Neuroendocrine Tumors
2
2023
122
0.280
Why?
Gallbladder Neoplasms
2
2024
20
0.270
Why?
Time Factors
10
2025
7109
0.260
Why?
Quality Indicators, Health Care
3
2026
343
0.250
Why?
Mastectomy, Segmental
2
2017
107
0.250
Why?
Lymphocytes
2
2025
379
0.240
Why?
Proportional Hazards Models
5
2025
1331
0.240
Why?
Inflammation
4
2025
2919
0.240
Why?
Aspartate Aminotransferases
1
2026
86
0.230
Why?
Survival Analysis
7
2024
1378
0.230
Why?
Vena Cava, Inferior
1
2026
80
0.230
Why?
Catheter Ablation
2
2008
355
0.220
Why?
Abdominal Neoplasms
1
2025
48
0.220
Why?
Time-to-Treatment
2
2025
257
0.220
Why?
Infusions, Intra-Arterial
1
2025
61
0.220
Why?
gamma-Glutamyltransferase
1
2025
42
0.220
Why?
Hyperglycemia
2
2020
384
0.220
Why?
Neoplasm Invasiveness
6
2026
504
0.220
Why?
Medical Futility
1
2025
32
0.210
Why?
Anastomotic Leak
1
2024
46
0.210
Why?
Portal Vein
1
2026
123
0.210
Why?
Abdomen, Acute
1
2004
20
0.210
Why?
Age Factors
5
2025
3347
0.210
Why?
End Stage Liver Disease
1
2025
84
0.200
Why?
Cohort Studies
10
2023
6077
0.200
Why?
Bacterial Infections
3
2006
247
0.200
Why?
Lymphopenia
1
2024
62
0.200
Why?
Biomarkers, Tumor
3
2025
1339
0.200
Why?
Chemotherapy, Adjuvant
6
2025
429
0.200
Why?
Odds Ratio
4
2019
1077
0.190
Why?
Combined Modality Therapy
6
2024
1271
0.190
Why?
Operative Time
4
2026
195
0.190
Why?
Cannabinoids
1
2025
182
0.190
Why?
Kaplan-Meier Estimate
4
2025
970
0.190
Why?
Practice Guidelines as Topic
2
2024
1591
0.190
Why?
Multilocus Sequence Typing
1
2022
16
0.190
Why?
SEER Program
2
2014
233
0.190
Why?
C-Reactive Protein
1
2025
429
0.190
Why?
Lymphoscintigraphy
2
2019
10
0.190
Why?
Sunburn
1
2002
26
0.180
Why?
Surgical Oncology
1
2022
30
0.180
Why?
Sunscreening Agents
1
2002
25
0.180
Why?
Nevus, Pigmented
1
2002
35
0.180
Why?
Patient Selection
2
2025
728
0.180
Why?
Pelvic Exenteration
2
2019
12
0.180
Why?
Lung Neoplasms
3
2023
2675
0.180
Why?
Prospective Studies
9
2025
8123
0.180
Why?
Killer Cells, Natural
1
2025
481
0.170
Why?
Klatskin Tumor
1
2021
18
0.170
Why?
Mastectomy
1
2023
189
0.170
Why?
Platelet Count
3
2026
95
0.170
Why?
Anesthetics, Inhalation
1
2021
52
0.160
Why?
Chemoradiotherapy
4
2023
238
0.160
Why?
Body Mass Index
3
2025
2458
0.160
Why?
Hyperthermia, Induced
2
2020
119
0.160
Why?
Propofol
1
2021
86
0.160
Why?
Organ Preservation
4
2023
123
0.150
Why?
Cancer Survivors
1
2025
348
0.150
Why?
Scalp
1
2019
38
0.150
Why?
Regression Analysis
2
2019
999
0.150
Why?
Artificial Intelligence
1
2024
389
0.140
Why?
Pancreatic Diseases
1
2019
64
0.140
Why?
Reoperation
3
2017
645
0.140
Why?
Registries
2
2021
2400
0.140
Why?
Skin Pigmentation
1
2019
44
0.140
Why?
Neutrophils
1
2024
1133
0.140
Why?
Phenotype
2
2026
3206
0.130
Why?
Appendiceal Neoplasms
1
2017
28
0.130
Why?
Referral and Consultation
1
2024
881
0.130
Why?
Population Surveillance
1
2021
481
0.130
Why?
Tomography, X-Ray Computed
3
2025
2786
0.130
Why?
Anesthesia
1
2021
257
0.130
Why?
Common Bile Duct Neoplasms
1
2017
28
0.130
Why?
Patient Acceptance of Health Care
1
2024
881
0.130
Why?
Patient Compliance
1
2021
589
0.130
Why?
Pylorus
1
2017
17
0.120
Why?
Gastric Outlet Obstruction
1
2017
12
0.120
Why?
Waiting Lists
2
2009
251
0.120
Why?
Carcinoma, Renal Cell
2
2026
231
0.120
Why?
Carcinoma, Ductal, Breast
1
2017
92
0.120
Why?
Radiotherapy, Intensity-Modulated
1
2018
143
0.120
Why?
Disease Management
1
2021
651
0.120
Why?
Analgesics, Opioid
1
2025
1221
0.120
Why?
Hospitals, High-Volume
1
2016
51
0.120
Why?
Nutritional Status
1
2019
346
0.120
Why?
Cancer Care Facilities
1
2016
48
0.120
Why?
Neoplasms
2
2022
2954
0.120
Why?
Neuromuscular Agents
1
2017
46
0.120
Why?
Hospitals
1
2021
738
0.120
Why?
Genital Neoplasms, Female
1
2017
100
0.120
Why?
Botulinum Toxins, Type A
1
2017
60
0.120
Why?
Obesity
2
2025
3131
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1998
0.110
Why?
Tomography, Emission-Computed, Single-Photon
1
2016
104
0.110
Why?
Cannabis
1
2023
521
0.110
Why?
Adenoma
1
2017
210
0.110
Why?
Patient Reported Outcome Measures
1
2019
516
0.110
Why?
Kidney Neoplasms
2
2026
419
0.110
Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1195
0.100
Why?
Delivery of Health Care
1
2021
947
0.100
Why?
Radiosurgery
1
2018
398
0.100
Why?
Morbidity
4
2021
319
0.100
Why?
Patient Readmission
1
2019
778
0.100
Why?
Antineoplastic Agents
3
2021
2219
0.100
Why?
Unnecessary Procedures
1
2014
56
0.100
Why?
Trauma Centers
2
2014
441
0.100
Why?
Hospital Mortality
4
2024
1051
0.100
Why?
Anti-Bacterial Agents
1
2004
1942
0.100
Why?
Abdomen
1
2013
142
0.090
Why?
Radiation Dosage
1
2014
193
0.090
Why?
Preoperative Period
2
2025
157
0.090
Why?
Renal Insufficiency
1
2013
173
0.080
Why?
Pandemics
3
2025
1707
0.080
Why?
Severity of Illness Index
3
2025
2921
0.080
Why?
Clinical Competence
1
2019
1272
0.080
Why?
Asia
2
2021
69
0.080
Why?
Triage
1
2012
243
0.080
Why?
Logistic Models
2
2025
2126
0.070
Why?
Europe
2
2021
421
0.070
Why?
Organ Preservation Solutions
2
2006
47
0.070
Why?
Graft Survival
2
2009
523
0.070
Why?
Kidney Transplantation
2
2013
735
0.070
Why?
Diagnostic Tests, Routine
2
2024
109
0.070
Why?
Brain Injuries
1
2014
499
0.070
Why?
Bile Ducts, Extrahepatic
1
2008
19
0.070
Why?
Laparotomy
1
2008
111
0.070
Why?
Practice Patterns, Physicians'
1
2017
1408
0.070
Why?
Biliary Tract Surgical Procedures
1
2008
26
0.070
Why?
Case-Control Studies
2
2007
3647
0.060
Why?
Cholangitis, Sclerosing
1
2008
56
0.060
Why?
Electrocoagulation
1
2007
35
0.060
Why?
Anus Neoplasms
1
2007
33
0.060
Why?
Intraoperative Care
1
2007
68
0.060
Why?
Congenital Hypothyroidism
1
1986
10
0.060
Why?
Brazil
2
2008
179
0.060
Why?
Multivariate Analysis
2
2025
1543
0.060
Why?
Young Adult
7
2022
14330
0.060
Why?
Guideline Adherence
2
2024
594
0.060
Why?
Retroperitoneal Neoplasms
1
2026
28
0.060
Why?
Vascular Patency
1
2026
115
0.060
Why?
Fluorouracil
2
2022
231
0.060
Why?
Ultrasonography, Interventional
1
2007
163
0.060
Why?
Mycophenolic Acid
1
2006
117
0.060
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
30
0.050
Why?
Sample Size
1
2025
124
0.050
Why?
Lymphocyte Count
1
2024
167
0.050
Why?
Adolescent
9
2022
22557
0.050
Why?
Wounds and Injuries
1
2012
959
0.050
Why?
Zygomycosis
1
2003
6
0.050
Why?
Radiotherapy, Adjuvant
2
2019
222
0.050
Why?
Bile Ducts, Intrahepatic
1
2024
62
0.050
Why?
Developmental Disabilities
1
1986
281
0.050
Why?
Sarcoma
1
2026
209
0.050
Why?
Cross-Sectional Studies
3
2026
5899
0.050
Why?
Cluster Analysis
1
2025
496
0.050
Why?
Comorbidity
2
2022
1665
0.050
Why?
Hepatocytes
1
2004
224
0.050
Why?
Antibiotic Prophylaxis
1
2004
140
0.050
Why?
Gastrectomy
1
2024
164
0.050
Why?
Biology
1
2023
90
0.050
Why?
Capecitabine
1
2022
56
0.040
Why?
Appendicitis
1
2004
151
0.040
Why?
Carcinoma, Squamous Cell
1
2007
628
0.040
Why?
Pneumonectomy
1
2023
169
0.040
Why?
Anesthesia, Intravenous
1
2021
23
0.040
Why?
Anesthetics, Intravenous
1
2021
67
0.040
Why?
Esophagogastric Junction
1
2021
54
0.040
Why?
Models, Biological
1
2008
1761
0.040
Why?
Induction Chemotherapy
1
2021
87
0.040
Why?
Surgical Wound Infection
1
2004
349
0.040
Why?
Thoracoscopy
1
2020
60
0.040
Why?
Liver
2
2006
1864
0.040
Why?
Image-Guided Biopsy
1
2019
41
0.040
Why?
Medical Oncology
1
2022
345
0.040
Why?
Adenocarcinoma, Mucinous
1
2020
76
0.040
Why?
Societies, Medical
1
2024
907
0.040
Why?
Perioperative Period
1
2017
69
0.030
Why?
Oxidative Stress
1
2004
1369
0.030
Why?
Reproducibility of Results
1
2025
3416
0.030
Why?
Occipital Bone
1
2017
18
0.030
Why?
Parotid Gland
1
2017
17
0.030
Why?
Gastric Emptying
1
2017
36
0.030
Why?
Carcinoma, Lobular
1
2017
59
0.030
Why?
Health Behavior
1
2002
802
0.030
Why?
Neck
1
2017
107
0.030
Why?
Longitudinal Studies
1
2024
3017
0.030
Why?
Sex Factors
1
2022
2107
0.030
Why?
Raffinose
2
2006
29
0.030
Why?
Consensus
1
2017
467
0.030
Why?
Allopurinol
2
2006
70
0.030
Why?
Perioperative Care
1
2018
235
0.030
Why?
Glucose
1
2020
1053
0.030
Why?
Drug Administration Schedule
1
2015
790
0.020
Why?
Adenosine
2
2006
256
0.020
Why?
Glutathione
2
2006
369
0.020
Why?
Glasgow Coma Scale
1
2014
211
0.020
Why?
Vital Signs
1
2012
39
0.020
Why?
Radiation Injuries
1
2014
149
0.020
Why?
New South Wales
1
2012
23
0.020
Why?
Incidence
1
2019
2936
0.020
Why?
Baltimore
1
2012
71
0.020
Why?
Italy
1
2012
118
0.020
Why?
Child
6
2014
22693
0.020
Why?
Magnetic Resonance Imaging
1
2025
3926
0.020
Why?
Disease Progression
1
2020
2867
0.020
Why?
Pharmaceutical Preparations
1
2013
172
0.020
Why?
Hospital Costs
1
2012
131
0.020
Why?
Biological Therapy
1
2011
30
0.020
Why?
Child, Preschool
4
2014
11913
0.020
Why?
Albuminuria
1
1992
190
0.020
Why?
Chi-Square Distribution
1
2012
517
0.020
Why?
Injury Severity Score
1
2012
572
0.020
Why?
Lung
1
2023
4122
0.020
Why?
Glomerular Filtration Rate
1
2013
745
0.020
Why?
Surveys and Questionnaires
1
2022
6073
0.020
Why?
Immunosuppressive Agents
1
2013
829
0.020
Why?
Carcinoembryonic Antigen
1
2008
40
0.020
Why?
Infant, Newborn
2
2014
6460
0.020
Why?
Antimetabolites, Antineoplastic
1
2008
108
0.020
Why?
Sensitivity and Specificity
1
2012
1998
0.020
Why?
Radiopharmaceuticals
1
2008
210
0.020
Why?
Fluorodeoxyglucose F18
1
2008
164
0.020
Why?
Retreatment
1
2007
79
0.020
Why?
Infant
3
2014
10114
0.020
Why?
Colorado
1
2017
4595
0.020
Why?
Cholecystectomy
1
2007
63
0.020
Why?
Incidental Findings
1
2007
81
0.020
Why?
Positron-Emission Tomography
1
2008
343
0.020
Why?
Neoplasm, Residual
1
2007
143
0.020
Why?
Biopsy, Needle
1
2007
183
0.020
Why?
Tablets, Enteric-Coated
1
2006
5
0.010
Why?
Hepatitis B
1
2007
66
0.010
Why?
Histidine
1
2006
67
0.010
Why?
Radiography
1
2008
861
0.010
Why?
Psychological Tests
1
1986
127
0.010
Why?
Graft Rejection
1
2009
516
0.010
Why?
Overweight
1
2010
614
0.010
Why?
Tryptophan
1
2006
184
0.010
Why?
Glutathione Disulfide
1
2004
30
0.010
Why?
Hepatitis C
1
2007
251
0.010
Why?
Insulin
2
2006
2525
0.010
Why?
Sulfamethoxypyridazine
1
1983
1
0.010
Why?
Trimethoprim
1
1983
7
0.010
Why?
Liver Function Tests
1
2004
103
0.010
Why?
Gastrointestinal Diseases
1
2006
220
0.010
Why?
Anti-Infective Agents, Urinary
1
1983
16
0.010
Why?
Amphotericin B
1
2003
36
0.010
Why?
Liver Diseases
1
2006
304
0.010
Why?
Antifungal Agents
1
2003
153
0.010
Why?
Immunocompromised Host
1
2003
201
0.010
Why?
Cause of Death
1
2004
456
0.010
Why?
Reperfusion Injury
1
2004
300
0.010
Why?
Urinary Tract Infections
1
1983
209
0.010
Why?
Cardiovascular Diseases
1
1992
2219
0.010
Why?
Diabetes Mellitus, Type 1
1
1992
3930
0.010
Why?
Cholesterol
1
1992
411
0.000
Why?
Blood Pressure
1
1992
1765
0.000
Why?
Sulfamethoxazole
1
1983
7
0.000
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
43
0.000
Why?
Escherichia coli Infections
1
1983
125
0.000
Why?
Drug Combinations
1
1983
400
0.000
Why?
Microbial Sensitivity Tests
1
1983
367
0.000
Why?
Escherichia coli
1
1983
832
0.000
Why?
Clinical Trials as Topic
1
1983
1064
0.000
Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)